By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


INSYS Therapeutics 

10220 South 51st Street
Suite 2
Phoenix  Arizona  85044  U.S.A.
Phone: 602-910-2617 Fax: 602-910-2627


Company News
INSYS Names Purdue Pharma L.P. Exec As New CEO, Effective April 17 3/27/2017 7:20:18 AM
DEA Schedules INSYS’ Syndros (Dronabinol Oral Solution) As Schedule II Drug 3/23/2017 11:32:41 AM
INSYS Announces Delay In The Release Of Its Fourth Quarter And Full Year 2016 Results 3/16/2017 10:35:05 AM
INSYS To Report Fourth Quarter And Full Year 2016 Results 3/2/2017 8:11:24 AM
INSYS Announces Use Of Cannabidiol Oral Solution For Compassionate Use Studies In Patients Completing Long-Term Safety Study 2/15/2017 8:24:28 AM
INSYS CEO to Retire, Interim Leader Named 1/9/2017 7:20:29 AM
INSYS Issues Statement Regarding Department Of Justice Press Release 12/9/2016 6:50:16 AM
Top INSYS Sales Execs Allegedly Took Doctor Out for "One of the Best Nights of His Life” to Boost Drug Sales 12/9/2016 6:01:20 AM
Why INSYS Billionaire CEO's Net Worth Dropped $470 Million Since September 11/7/2016 7:08:23 AM
INSYS Reports Third Quarter 2016 Results 11/3/2016 10:19:28 AM